Last update :
12/12/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter

Search Search

Monograph Cyclophosphamide injectionAnticancer drug Cyclophosphamide (Great Britain, United States of America, Saudi Arabia, New Zealand)
ATC : L01AA01
Monograph Cyclophosphamide Oral solutionAnticancer drug ATC : L01AA01
Monograph Cyclophosphamide CapsuleAnticancer drug ATC : L01AA01
References 40 Pharm Sci Communications Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
References 50 Am J Health-Syst Pharm Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
References 170 Am J Hosp Pharm Effect of briefly heating cyclophosphamide solutions.
References 172 J Parenter Sci Technol Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
References 1728 Pharmazie Stability of cyclophosphamide containing infusions.
References 1833 Ann Pharmacotherapy Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
References 2000 J Pharm Biomed Anal Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
References 2016 Am J Health-Syst Pharm Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
References 3096 Ann Pharmacotherapy Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
References 4865 Dr REDDY laboratoire Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
References 4989 Dr REDDY Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025
  Mentions Légales